X

Vous n'êtes pas connecté

Maroc Maroc - CARIBBEANNEWSGLOBAL.COM - A La Une - 27/Aug 01:14

FDA clears first device to enable automated insulin dosing for individuals with Type 2 Diabetes

WASHINGTON, USA – The US Food and Drug Administration, on Monday, expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic controller previously indicated for the management of type 1 diabetes in individuals two years and older, to also include management of type 2 diabetes in individuals 18 years and older. An interoperable […]

Articles similaires

The $10,000 price tag for latest diabetes technology leaves many children with type 1 going without

thewest.com.au - 14/Sep 13:31

Automated insulin delivery is the gold standard in type 1 diabetes management for children, but a lack of subsidies and the $10,000 price tag means...

Sorry! Image not available at this time

New treatment for type 2 diabetes could stop insulin usage

knowridge.com - 13/Sep 10:27

Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...

Sorry! Image not available at this time

New treatment for type 2 diabetes could stop insulin usage

knowridge.com - 13/Sep 10:27

Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...

Sorry! Image not available at this time

Insulin Delivery Devices Market worth $46.2 billion by 2028 | MarketsandMarkets

mountaintoday.in - 13/Sep 18:36

In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes management....

Study shows beta cells can function independently for glycemic control

news.medical.net - 03/Sep 10:56

Our glycemic balance is based on the ability of the pancreatic beta cells to detect glucose and secrete insulin to maintain our blood sugar levels. If...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Research finds new health risks of common diabetes drugs

knowridge.com - 06/Sep 10:31

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Sorry! Image not available at this time

Research finds new health risks of common diabetes drugs

knowridge.com - 06/Sep 10:31

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Early Glycemic Control in Gestational Diabetes Reduces Childhood Obesity

medindia.net - 12/Sep 21:05

Learn about the importance of maternal blood sugar management during pregnancy which can significantly reduce childhood obesity risk.